Bell Potter says this cheap ASX stock can rocket 100%

The broker thinks this could be a smashing buy for investors.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Wouldn't it be nice to double your money with an investment?

Well, that's what could happen with the cheap ASX stock in this article, according to analysts at Bell Potter.

Man with rocket wings which have flames coming out of them.

Image source: Getty Images

Which ASX stock?

The stock that could be seriously undervalued, according to the broker, is AMA Group Ltd (ASX: AMA).

It is the largest accident repair group in Australia with approximately 140 vehicle panel repair shops.

Bell Potter highlights that the market doesn't appear to believe the stock will achieve its earnings guidance in FY 2026. It said:

The current AMA share price suggests the market has some doubt whether the FY26 guidance of normalised EBITDA pre-AASB 16 of $70-75m is achievable after the company reported $30.5m in H1. We, however, believe the guidance is well achievable as, firstly, Q3 and Q4 are typically seasonally strong quarters and, secondly, the guidance only implies a similar underlying 2HFY26 result relative to 2HFY25.

There is actually some prospect of a better 2HFY26 result relative to 2HFY25 after CEO Ray Smith-Roberts suggested on the recent 1HFY26 result call that a margin approaching the medium term target of 10% may be achievable in 4QFY26. Our Q3 and Q4 margin forecasts are 6.7% and 8.3% – which put us comfortably within the guidance range – so a margin closer to 10% in Q4 could see a full year result towards the top end of the range.

Huge potential returns

In light of this, Bell Potter believes the ASX stock deserves to trade on higher multiples and is tipping huge potential returns over the next 12 months.

According to the note, the broker has put a buy rating and $1.25 price target on its shares. Based on its current share price of 62 cents, this implies potential upside of 100% for investors.

Commenting on its buy recommendation, Bell Potter said:

There is also no change in our target price of $1.25 which we only recently updated with the release of the H1 result last month. We note that, at the current share price, the EV/EBITDA multiple – using our pre-AASB 16 forecasts – is only 4.4x in FY26 and 3.8x in FY27. We also note even the PE ratio looks reasonable on 29x in FY26 and 15x in FY27.

And we remind that the Balance Sheet is in good shape with net debt of $21m at 31 December and is expected to be lower at 30 June with the seasonally stronger H2. We also highlight there is the prospect of a resumption of dividends this year with a forecast final dividend of 1.0c depending on M&A activity.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

a miner holds his thumb up as he holds a device in his other hand.
Resources Shares

Experts name 3 ASX mining shares to buy after March sell-off

Investors took profits amid fears the fuel crisis could impact miners' production and earnings.

Read more »

A woman holds her finger to the side of her face and looks upwards as she thinks about something.
Broker Notes

4 ASX shares at 52-week lows: Buy, hold, or sell?

Here's what the experts think.

Read more »

A female athlete in green spandex leaps from one cliff edge to another representing 3 ASX shares that are destined to rise and be great
Broker Notes

Up 57% since February, why Telix shares could keep leaping higher in 2026

A leading analyst believes investors are undervaluing Telix shares. But why?

Read more »